R&D Systems™ Recombinant Human Thrombopoietin (E. coli-expressed), CF
A key regulator of megakaryocytopoiesis and thrombopoiesis
Supplier: R&D Systems™ 288TPE01M
DescriptionThe Recombinant Human Thrombopoietin (E. coli-expressed) is derived from E. coli. The Recombinant Human Thrombopoietin (E. coli-expressed) has been validated for the following applications: Bioactivity.
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining|
|E. coli-derived human Thrombopoietin/Tpo protein Ser22-Leu195|
|<0.10 EU per 1 ug of the protein by the LAL method|
|Reconstitute at 100 ug/mL in PBS|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, ≤ -20°C under sterile conditions after reconstitution.|
|Lyophilized from a 0.2 um filtered solution in PBS with Trehalose|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok